MetaCap

Immunome Insider Trades

NASDAQ: IMNMHealth CareBiotechnology: Pharmaceutical PreparationsUSD

19.55+0.24 (+1.24%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
11 · $2.31M
Sales
28 · $27.51M
Shares bought / sold
111.47K / 1.23M
Net activity
Net selling $25.2 million

Immunome insider activity

Over the last 12 months, Immunome insiders reported 64 transactions on SEC Form 4: 11 open-market purchases and 28 sales. Insiders bought $2.3 million and sold $27.5 million worth of stock, for net insider selling of $25.2 million. The largest seller was Barchas Isaac, with $18.3 million in reported sales.

The most recent filing shows Higgins Jack (Chief Scientific Officer) reporting a transaction in 18,000 shares at $1.35 on Sep 11, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put IMNM's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

IMNM insider transactions

Immunome insider transactions
DateInsiderTypeSharesValueFiling
Sep 11, 2026Higgins JackChief Scientific OfficerGift8,800—Form 4
Sep 11, 2026Higgins JackChief Scientific OfficerSale13,200$334.22KForm 4
Sep 11, 2026Higgins JackChief Scientific OfficerOption exercise18,000$24.30KForm 4
Aug 12, 2026Barchas IsaacDirectorSale11,048$301.06KForm 4
Aug 11, 2026Barchas IsaacDirectorSale62,291$1.63MForm 4
Aug 10, 2026Barchas IsaacDirectorSale10,125$263.96KForm 4
Aug 7, 2026Barchas IsaacDirectorSale15,248$397.36KForm 4
Aug 6, 2026Barchas IsaacDirectorSale20,840$543.09KForm 4
Aug 4, 2026Horn KinneyCHIEF BUSINESS OFFICERSale90,616$2.27MForm 4
Aug 4, 2026Horn KinneyCHIEF BUSINESS OFFICEROption exercise40,250$426.65KForm 4
Aug 4, 2026Horn KinneyCHIEF BUSINESS OFFICEROption exercise50,366$650.73KForm 4
Jul 23, 2026SIEGALL CLAY BPresident and CEOAward180,000—Form 4
Jul 23, 2026Rosett MaxChief Financial OfficerAward47,250—Form 4
Jul 23, 2026Higgins JackChief Scientific OfficerAward38,250—Form 4
Jul 23, 2026Stoneman Sandra G.CHIEF LEGAL OFFICER & GCAward38,250—Form 4
Jul 23, 2026Lechleider RobertChief Medical OfficerAward54,000—Form 4
Jul 23, 2026Tsai PhilipChief Technical OfficerAward38,250—Form 4
Jul 23, 2026Horn KinneyCHIEF BUSINESS OFFICERAward31,250—Form 4
Jul 7, 2026Barchas IsaacDirectorSale16,906$409.13KForm 4
Jul 7, 2026Horn KinneyCHIEF BUSINESS OFFICERSale1,092$27.30KForm 4
Jul 7, 2026Horn KinneyCHIEF BUSINESS OFFICEROption exercise1,092$14.11KForm 4
Jul 6, 2026Barchas IsaacDirectorSale83,094$2.00MForm 4
Jul 2, 2026Barchas IsaacDirectorSale24,335$567.74KForm 4
Jul 2, 2026Barchas IsaacDirectorSale75,665$1.69MForm 4
Jul 2, 2026Lechleider RobertChief Medical OfficerSale16,072$376.73KForm 4
Jul 2, 2026Lechleider RobertChief Medical OfficerSale16,214$369.03KForm 4
Jul 2, 2026Lechleider RobertChief Medical OfficerSale22,714$498.57KForm 4
Jul 2, 2026Lechleider RobertChief Medical OfficerOption exercise55,000$480.15KForm 4
Jun 30, 2026Barchas IsaacDirectorSale101,050$2.13MForm 4
Jun 25, 2026Lechleider RobertChief Medical OfficerSale14,420$297.92KForm 4
Jun 25, 2026Lechleider RobertChief Medical OfficerSale40,580$793.74KForm 4
Jun 25, 2026Lechleider RobertChief Medical OfficerOption exercise55,000$480.15KForm 4
Jun 15, 2026Rosett MaxChief Financial OfficerSale60,000$1.09MForm 4
Jun 15, 2026Rosett MaxChief Financial OfficerOption exercise60,000$63.00KForm 4
Jun 5, 2026BIENAIME JEAN JACQUESDirectorBuy1,000$19.27KForm 4
Jun 5, 2026BIENAIME JEAN JACQUESDirectorBuy3,500$68.11KForm 4
Jun 5, 2026BIENAIME JEAN JACQUESDirectorBuy6,000$116.88KForm 4
Jun 5, 2026BIENAIME JEAN JACQUESDirectorSale10,000$194.10KForm 4
Jun 5, 2026BIENAIME JEAN JACQUESDirectorSale500$9.72KForm 4
May 15, 2026BIENAIME JEAN JACQUESDirectorBuy5,000$103.50KForm 4
Apr 2, 2026Rosett MaxChief Financial OfficerSale1,344$30.21KForm 4
Apr 2, 2026Rosett MaxChief Financial OfficerSale63,656$1.39MForm 4
Apr 2, 2026Rosett MaxChief Financial OfficerOption exercise39,713$53.61KForm 4
Apr 2, 2026Rosett MaxChief Financial OfficerOption exercise31,848$33.44KForm 4
Apr 2, 2026Higgins JackChief Scientific OfficerSale9,438$204.24KForm 4
Mar 30, 2026Higgins JackChief Scientific OfficerGift6,291—Form 4
Mar 27, 2026SIEGALL CLAY BPresident and CEOBuy25,450$500.60KForm 4
Mar 23, 2026WAGENHEIM PHILIPDirectorSale28,200$582.33KForm 4
Mar 20, 2026WAGENHEIM PHILIPDirectorSale36,800$753.30KForm 4
Mar 11, 2026BIENAIME JEAN JACQUESDirectorBuy1,000$21.55KForm 4
Mar 10, 2026BIENAIME JEAN JACQUESDirectorBuy1,000$22.12KForm 4
Dec 30, 2025SIEGALL CLAY BPresident and CEOBuy4,729$100.02KForm 4
Dec 22, 2025Barchas IsaacDirectorSale11,251$251.35KForm 4
Dec 22, 2025Barchas IsaacDirectorSale371,949$8.08MForm 4
Dec 19, 2025Tsai PhilipChief Technical OfficerBuy10,000$204.90KForm 4
Dec 19, 2025Higgins JackChief Scientific OfficerGift1,000—Form 4
Dec 19, 2025Higgins JackChief Scientific OfficerGift1,000—Form 4
Dec 19, 2025Higgins JackChief Scientific OfficerGift1,000—Form 4
Dec 19, 2025Higgins JackChief Scientific OfficerGift1,000—Form 4
Dec 19, 2025Higgins JackChief Scientific OfficerGift1,000—Form 4
Dec 19, 2025Higgins JackChief Scientific OfficerGift1,000—Form 4
Dec 19, 2025SIEGALL CLAY BPresident and CEOGift200,000—Form 4
Dec 19, 2025SIEGALL CLAY BPresident and CEOBuy7,278$149.05KForm 4
Dec 18, 2025SIEGALL CLAY BPresident and CEOBuy46,511$999.99KForm 4
Sep 10, 2025Higgins JackChief Scientific OfficerOption exercise22,000$29.70KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related